Dr Nicola A Francalancia, MD | |
246 Pleasant St Ste 103, Concord, NH 03301 | |
(603) 224-1725 | |
(603) 227-7557 |
Full Name | Dr Nicola A Francalancia |
---|---|
Gender | Male |
Speciality | Cardiac Surgery |
Experience | 36 Years |
Location | 246 Pleasant St Ste 103, Concord, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1871584003 | NPI | - | NPPES |
200863950 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 20008 (New Hampshire) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Concord Regional Vna | Concord, NH | Home health agency |
Concord Hospital | Concord, NH | Hospital |
Lakes Region General Hospital | Laconia, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Concord Hospital Inc | 6103721790 | 462 |
News Archive
Acutely ill heart attack patients who received both aspirin and a new reversible oral anti-platelet medication had fewer cardiac events than patients on aspirin and the most commonly used, irreversible anti-platelet drug, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
A US study has found that even subtle changes in the levels of PTEN, a protein that blocks cancer development, may significantly increase a person's chances of developing cancer.
Even before conception, a son's vulnerability for alcohol use disorders could be shaped by a father who chronically drinks to excess, according to a new animal study from the University of Pittsburgh School of Medicine.
Sens. Max Baucus and Harry Reid are predicting that a health care overhaul in the Senate will attract the votes of all Democrats in the Senate — and maybe even more than one Republican.
Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy.
› Verified 2 days ago
Entity Name | Concord Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194778571 PECOS PAC ID: 6103721790 Enrollment ID: O20040405000916 |
News Archive
Acutely ill heart attack patients who received both aspirin and a new reversible oral anti-platelet medication had fewer cardiac events than patients on aspirin and the most commonly used, irreversible anti-platelet drug, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
A US study has found that even subtle changes in the levels of PTEN, a protein that blocks cancer development, may significantly increase a person's chances of developing cancer.
Even before conception, a son's vulnerability for alcohol use disorders could be shaped by a father who chronically drinks to excess, according to a new animal study from the University of Pittsburgh School of Medicine.
Sens. Max Baucus and Harry Reid are predicting that a health care overhaul in the Senate will attract the votes of all Democrats in the Senate — and maybe even more than one Republican.
Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Nicola A Francalancia, MD 246 Pleasant St Ste 103, Concord, NH 03301-2548 Ph: (603) 224-1725 | Dr Nicola A Francalancia, MD 246 Pleasant St Ste 103, Concord, NH 03301 Ph: (603) 224-1725 |
News Archive
Acutely ill heart attack patients who received both aspirin and a new reversible oral anti-platelet medication had fewer cardiac events than patients on aspirin and the most commonly used, irreversible anti-platelet drug, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
A US study has found that even subtle changes in the levels of PTEN, a protein that blocks cancer development, may significantly increase a person's chances of developing cancer.
Even before conception, a son's vulnerability for alcohol use disorders could be shaped by a father who chronically drinks to excess, according to a new animal study from the University of Pittsburgh School of Medicine.
Sens. Max Baucus and Harry Reid are predicting that a health care overhaul in the Senate will attract the votes of all Democrats in the Senate — and maybe even more than one Republican.
Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy.
› Verified 2 days ago
Louis Russo, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St., Memorial Building, West, Ground Floor, Concord, NH 03301 Phone: 603-224-1725 Fax: 603-227-7557 | |
Alexandru Mihai Vaida, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-1725 Fax: 603-227-7557 | |
Gerald L Sardella, MD FACS Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-1725 Fax: 603-224-6094 |